Form D · Biotechnology
Imunon, Inc.
Lawrenceville, NJ · CIK 0000749647
Offering snapshot reported May 28, 2025 · SEC filing
- Reported sold
- $3.25M Offering amount: $3.25M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 27, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 28, 2025 | Initial | $3,250,001 | No comparison | 3 | SEC filing |
| Aug 16, 2024 | Initial | $10,000,000 | No comparison | 4 | SEC filing |
| Jun 8, 2015 | Initial | $5,070,000 | No comparison | 3 | SEC filing |
| Jun 24, 2014 | Initial | $8,500,000 | No comparison | 1 | SEC filing |
| Jun 14, 2011 | Initial | $8,580,000 | No comparison | 31 | SEC filing |
| Jul 26, 2010 | Initial | $139,744 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $228K
- Finders' fees
- $0
- Form D file number
- 021-547406
Warrants and pre-funded warrants to purchase common stock and shares of common stock underlying such warrants
In addition to the cash fee above, the Company paid certain expenses and issued a warrant to purchase up to 361,111 shares of the Company's common stock at an exercise price of $0.5625 per share to H.C. Wainwright, LLC.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 000000375 | |
| Brookline Capital Markets, a division of Arcadia Securities, LLC | 000044656 |
Source: Form D, filed May 28, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Khursheed Anwer | Executive |
| Nicholas Borys | Executive |
| Donald P. Braun | Director |
| Augustine Chow | Director |
| Jeffrey W. Church | Executive |
| James E. Dentzer | Director |
| Susan Eylward | Executive |
| Douglas Faller | Executive |
| Frederick J. Fritz | Director |
| David Gaiero | Executive |
| Robert W. Hooper | Director |
| Stacy R. Lindborg | Director, Executive |
| Max E. Link | Director |
| Alberto Martinez | Director |
| Gary W. Pace | Director |
| Christine Pellizzari | Director |
| Robert A Reed | Executive |
| Michael H. Tardugno | Director, Executive |
| Timothy J. Tumminello | Executive |
| Gregory Weaver | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
997 Lenox Drive Suite 100
Lawrenceville, NJ, 08648-2311
Lawrenceville, NJ, 08648-2311